Work

Supplementary Figure 2 from Human CD59 Inhibitor Sensitizes Rituximab-Resistant Lymphoma Cells to Complement-Mediated Cytolysis

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Figure 2 from Human CD59 Inhibitor Sensitizes Rituximab-Resistant Lymphoma Cells to Complement-Mediated Cytolysis

DOI: 10.1158/0008-5472.22390964

Authors: Weiguo Hu, Xiaowen Ge, Tao You, Ting Xu, Jinyan Zhang, Gongxiong Wu, Zhihai Peng, Michael Chorev, Bertal H. Aktas, Jose A. Halperin, Jennifer R. Brown, Xuebin Qin

Language: English

Topic: Complement system in diseases

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361832481

Cites:

Cited by:

Related to: 10